The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Off-label drug use in hospitalized children: a prospective observational study at Gondar University Referral Hospital, Northwestern Ethiopia
Open accessAbstract
Most of the medications which are currently used for the treatment of childhood diseases are either not licensed or being prescribed outside the terms of the product license (off-label prescribing). This study aimed at determining the extent of unlicensed and off-label drug uses and associated factors in children hospitalized in Gondar University Referral Hospital, Northwest Ethiopia. An institution-based prospective cross-sectional study was employed from April 15 to July 15, 2016. A total of 243 pediatric patients admitted to Gondar university referral hospital were included in the study using simple random sampling method. Data were collected using structured questionnaire, and the data collected were entered and analyzed using Statistical Packages for Social Sciences (SPSS) version 20. From the total of 800 drugs prescribed, 607 (75.8%) were off-label. Off-label medicine use was frequently observed in antimicrobials (60.6%) followed by central nervous system drugs (14.3%). The extent off-label prescribing was highest in age group of 6–13 years (30%). Inappropriate dosing and frequency (42.3%) were the most common reason for off-label medicine use. Having other variables controlled, age group and undergoing surgical procedure remained to be significant predictors of off-label prescribing in the multivariate regression analysis. Implementing evidence-based approach in prescribing by generating more quality literatures on the safety profile and effectiveness of off-label would improve the injudicious use of drugs in pediatric population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“transplanting adult evidence into children can yield sub-therapeutic dosing, diminished efficacy, or an elevated risk of adverse reactions [2-4].”
From PED-X-Bench: A Benchmark of Adult-to-Pediatric Extrapolation Decisions in FDA Drug Labels (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Because growth and maturation reshape both pharmacokinetics and disease biology”
From PED-X-Bench: A Benchmark of Adult-to-Pediatric Extrapolation Decisions in FDA Drug Labels (2025) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Survey of unlicensed and off label drug use in paediatric wards in European countries
Conroy, S. (2000) · BMJ · doi:10.1136/bmj.320.7227.79 · Cited by 744
Unlicensed and off label drug use in paediatric wards: prospective study
Turner, S. J., Longworth, A., Nunn, A. J., & Choonara, I. (1998) · BMJ · doi:10.1136/bmj.316.7128.343 · Cited by 318
Cuzzolin, L., Atzei, A., & Fanos, V. (2006) · Expert Opinion on Drug Safety · doi:10.1517/14740338.5.5.703 · Cited by 252
Drug use in children: cohort study in three European countries
Sturkenboom, M., Verhamme, K. M. C., Nicolosi, A., Murray, M. L., Neubert, A. C., Caudri, D., Picelli, G., Sen, E. F., Giaquinto, C., Cantarutti, L., et al. (2008) · BMJ · doi:10.1136/bmj.a2245 · Cited by 234
Off-Label Drug Use in Pediatric Patients
Kimland, E. E., & Odlind, V. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.26 · Cited by 223
Off-label Drug Use in Hospitalized Children
Shah, S. S., Hall, M., Goodman, D. M., Feuer, P., Sharma, V., Fargason, C. A., Hyman, D., Jenkins, K. J., White, M. L., Levy, F. H., et al. (2007) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.161.3.282 · Cited by 222
Drug prescriptions to outpatient children: a review of the literature
Clavenna, A., & Bonati, M. R. (2009) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-009-0679-7 · Cited by 148
Using antibiotics responsibly: right drug, right time, right dose, right duration
Dryden, M., Johnson, A. P., Ashiru-Oredope, D. A. I., & Sharland, M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr370 · Cited by 141
Risk Factors for Unlicensed and Off-Label Drug Use in Children Outside the Hospital
Schirm, E., Tobi, H., & den Berg, L. T. W. D. J. (2003) · PEDIATRICS · doi:10.1542/peds.111.2.291 · Cited by 99
The status of paediatric medicines initiatives around the world—what has happened and what has not?
Hoppu, K., Anabwani, G. M., García‐Bournissen, F., Gazarian, M., Kearns, G. L., Nakamura, H., Peterson, R. G., Ranganathan, S. S., & de Wildt, S. N. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-011-1089-1 · Cited by 97
Research works printed but not linked: 1
- Turner, 1998, Unlicensed and off-label drug use in paediatric wards: prospective study, BMJ, 316, 343, 10.1136/bmj.316.7128.343 · DOI
Cited by
Sorted by citations
Off-label and unlicensed drug use in children population
Moulis, F., Durrieu, G., & Lapeyre‐Mestre, M. (2018) · Therapies · doi:10.1016/j.therap.2018.02.002 · Cited by 56
Gidey, M. T., Gebretsadkan, Y. G., Tsadik, A. G., Welie, A. G., & Assefa, B. T. (2020) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-020-0809-5 · Cited by 20
Off‑label and unapproved pediatric drug utilization: A meta‑analysis
Yuan, X., Gao, J., Yang, L., Tan, Y., & Bajinka, O. (2024) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2024.12701 · Cited by 17
Kotb, M. A., Mosallam, D., Basanti, C. W. S., Sorogy, S. T. M. E., Badr, A., Baky, H. A. E., & Draz, I. H. (2020) · Medicine · doi:10.1097/md.0000000000018730 · Cited by 12
Obura, B., Alele, P. E., & Obua, C. (2020) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-020-01175-1 · Cited by 5
Gambaran Penggunaan Obat Off-Label Pada Pasien Pediatrik Rawat Inap di Rumah Sakit
Tuloli, T. S., Rasdianah, N., Makkulawu, A., Papeo, D. R. P., & Datau, M. (2022) · Indonesian Journal of Pharmaceutical Education · doi:10.37311/ijpe.v2i2.11449 · Cited by 5
Peresepan Obat “Off-Label” Pada Anak Dengan Penyakit Infeksi Saluran Pernapasan Akut
Putra, O. N., Anggraini, E. D., & Faizah, A. K. (2021) · Lumbung Farmasi Jurnal Ilmu Kefarmasian · doi:10.31764/lf.v2i1.3729 · Cited by 5
Hafeez, M., Bukhari, N. I., Abbas, N. A., Hussain, K., Hussain, A., & Saleem, Z. (2021) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v18i10.28 · Cited by 5
Albóniga, O. E., González, O., Blanco, M. E., & Alonso, R. M. (2022) · Metabolites · doi:10.3390/metabo12080739 · Cited by 4
Almintakh, L. S., Dossary, M. F. A., Altesha, A. M., Alqahtani, R. F., Al-Somali, S. M., Banu, N., Ali, M. D., & Ahmed, A. (2024) · Current Pediatric Reviews · doi:10.2174/0115733963298903240614072717 · Cited by 4
Sridharan, K., Jufairi, M. A., & Ansari, E. A. (2021) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-200058 · Cited by 4
Rahayuningsih, N., Priatna, M., & Sulistiani, D. A. (2024) · Pharmacology and Clinical Pharmacy Research · doi:10.15416/pcpr.v8i3.48103 · Cited by 1
Rivero, R., Strusberg, I., Joekes, S., Yori, S., Herrero, C. B., Rousseau, M. N., & Fontana, D. (2024) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v81.n2.42261 · Cited by 1
Kateel, R., Hegde, S., & Holla, S. N. (2025) · Therapeutic Advances in Drug Safety · doi:10.1177/20420986251386215 · Cited by 1
Current issues related to the off-label use of drugs and their potential solutions
Radaeva, К. S., & Андреевна, М. С. (2024) · Real-World Data & Evidence · doi:10.37489/2782-3784-myrwd-48 · Cited by 1
The peculiarities of off-label use of drugs in pediatrics
Drohovoz, S. M., Butko, Y. O., Іvantsyk, L. B., Shchokina, C. H., Bielik, H., & Лук’янчук, В. Д. (2020) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2020.5.214751 · Cited by 1
PED-X-Bench: A Benchmark of Adult-to-Pediatric Extrapolation Decisions in FDA Drug Labels
Srinivasan, A., Berkowitz, J., Friedrich, N. A., Tsang, K., Kuchi, A., Acitores, J., Zietz, M., Czarny, R. S., Liu, H., & Tatonetti, N. P. (2025) · medRxiv · doi:10.1101/2025.05.22.25328187
Svendblad, P. H. (2019) · Realidad y Reflexión · doi:10.5377/ryr.v49i49.8062
Off-label Drug Prescribing: Deciphering the Ambiguity
Qadeer, F., Abidi, A., Fatima, F., & Khan, A. Z. (2020) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2020.7.1.28
Alolayan, A., Almansour, B., Barnawi, Y., Munawar, H., Almodamegh, S., Aldossari, H., & Mansy, W. (2021) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2021/v33i19a31329
Metadata
- Authors
- Tefera, Y. G., Gebresillassie, B. M., Mekuria, A. B., Abebe, T. B., Erku, D. A., Seid, N., & Beshir, H. B.
- Affiliations
- University of Gondar (ET)
- Department of Pharmaceutical Chemistry; School of Pharmacy; university of Gondar; Gondar Amhara Ethiopia
- Corresponding author
- Tefera, Yonas G.
- Venue
- Pharmacology Research & Perspectives
- Publisher
- Wiley
- Published
- 2017-03-17
- Volume
- 5
- Issue
- 2
- Pages
- e00304
- ISSN
- 2052-1707 (ISSN-L)
- PMC
- PMC5368968
- OpenAlex
- W2595606553
- Cited by
- 21
- References
- 27
- Citations by year
- 2025: 2 · 2024: 5 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 1 · 2017: 1
- FWCI
- 2.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Pharmacology Research & Perspectives (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Nursing › Issues, ethics and legal aspects › Pharmaceutical industry and healthcare
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- off-label drug use, pediatric drug use, hospitalized children, antimicrobial agents, inappropriate dosing, surgical procedures, evidence-based prescribing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
